Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 5.4.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)30171LEKOKLAR 500 mg filmom obalené tablety (tbl flm 14x500 mg (blis.PVC/PVDC/Al))4.4.2023O
 5.4.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)30181LEKOKLAR 250 mg filmom obalené tablety (tbl flm 14x250 mg (blis. PVC/PVDC/Al))4.4.2023O
 5.4.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)38295Fentanyl Sandoz 50 µg/h matrix transdermálna náplasť (emp tdm 5x50 µg/1 h)4.4.2023O
 5.4.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)45362Omeprazol Sandoz 40 mg prášok na infúzny roztok (plv ifo 1x40 mg (liek.inj.skl.))4.4.2023O
 5.4.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)45710Lekoklar XL 500 mg tablety s riadeným uvoľňovaním (tbl mod 7x500 mg (blis.Al/Al))4.4.2023O
 5.4.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)54211Letrozol Sandoz 2,5 mg filmom obalené tablety (tbl flm 100x2,5 mg (blis.PVC/Al))4.4.2023O
 5.4.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)5431ATelmisartan/Hydrochlorotiazid Sandoz 80 mg/12,5 mg (tbl obd 28x80 mg/12,5 mg (blis.Al/Al))4.4.2023O
 5.4.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)5442ATelmisartan/Hydrochlorotiazid Sandoz 80 mg/25 mg (tbl obd 28x80 mg/25 mg (blis.Al/Al))4.4.2023O
 5.4.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)74991Amoksiklav 156,25 mg/5 ml (plu por 1x100 ml (fľ.skl.hnedá+(PP/PE) uzáver so závit.+(PP/PE)odmer.striek.))4.4.2023O
 5.4.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)7726BDuloxetin Sandoz 60 mg (cps end 30x60 mg (blis.PVC/PE/PCTFE/Al))4.4.2023O
 5.4.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)85592EDICIN 0,5 g prášok na infúzny roztok (plv ifo 1x0,5 g (liek.skl.))4.4.2023O
 5.4.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)89109PERINDASAN 2 mg/0,625 mg tablety (tbl 30x2 mg/0,625 mg (blis.Al/Al))4.4.2023O
 5.4.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)96416Amoksiklav 312,5 mg/5 ml (plu por 1x100 ml (fľ.skl.hnedá+(PP/PE)uzáver so závit.+(PP/PE)odmer.striek.))4.4.2023O
 4.4.2023Zentiva a.s. (ZNT-SK-2)99336GLURENORM (tbl 30x30 mg (blis.PVC/Al))4.4.2023R
 4.4.2023Zentiva, k.s. (ZNT-1)10406Carzap 8 mg (tbl 28x8 mg (blis.PVC/PVDC/Al))4.4.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To